Scientists from the National University of Singapore (NUS) have discovered that the evasion of apoptosis is a key driver of drug resistance in patients with relapsed acute myeloid leukaemia (AML), a type of aggressive blood cancer.
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA 510(k) Cleared 6-Lead ECG Device
What You Should Know: – WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in
May 22, 2024